TP53 and gastric cancer: Gastric cancer-related molecular pathology studies have yet to gain attention in Rwanda, and given the scarcity of genomic data in Rwanda in general, this study aimed at obtaining information on TP53 mutation status in Rwandan patients with gastric cancer.